Wyniki wyszukiwania - BazTech

Ograniczanie wyników

2 Acta Chromatographica

Powiadomienia systemowe

Sesja wygasła!

Znaleziono wyników: 2

Liczba wyników na stronie

Wyniki wyszukiwania

Wyszukiwano:
w słowach kluczowych: repaglinide

Sortuj według:

Ogranicz wyniki do:

Development and validation of stability-indicating high-performance thin-layer chromatography method for estimation of repaglinide in bulk and in pharmaceutical formulation

Jain P. S., Patel M. K., Surana S. J.

Acta Chromatographica

2013

Vol. 25, no. 3

531--544

A simple, selective, precise, and stability-indicating high-performance thin-layer chromatographic method for analysis of repaglinide both in a bulk and in pharmaceutical formulation has been developed and validated. The method employed high-performance thin-layer chromatography (HPTLC) aluminum plates precoated with silica gel 60 RP-18 F254 as the stationary phase. The solvent system consisted of chloroform-methanol-ammonia (4.5:0.8:0.05, v/v). The system was found to give compact spot for repaglinide (RF value of 0.55 ± 0.03). Densitometric analysis of repaglinide was carried out in the absorbance mode at 288 nm. The linear regression analysis data for the calibration plots showed good linear relationship with r2 = 0.998 ± 0.0015 with respect to peak area in the concentration range 600–1600 ng per spot. The mean value ± SD of slope and intercept were 3.38 ± 1.47 and 986.9 ± 108.78, with respect to peak area. The method was validated for precision, recovery, and robustness. The limits of detection and quantification were 22.64 and 68.84 ng per spot, respectively. Repaglinide was subjected to acid and alkali hydrolysis, oxidation, and thermal degradation. The drug undergoes degradation under acidic and basic conditions. This indicates that the drug is susceptible to acid and base. The degraded product was well resolved from the pure drug with significantly different RF value. Statistical analysis proves that the method is repeatable, selective, and accurate for the estimation of investigated drug. The proposed developed HPTLC method can be applied for identification and quantitative determination of repaglinide in bulk drug and pharmaceutical formulation.

Validated stability-indicating RP-HPLC UV method for simultaneous determination of metformin and repaglinide

Joshi S. S, Nahire R. R, Shastri N. R, Surendranath K. V, Satish J

Acta Chromatographica

2012

Vol. 24, no. 3

419--432

A simple, rapid, precise, and accurate, stability-indicating reversed phase high performance liquid chromatographic method was developed and validated for simultaneous determination of metformin HCl and repaglinide. The chromatographic separation was achieved on YMC Pack AM ODS (5 μm, 250 mm length × 4.6 mm i.d.) column at a detector wavelength of 210 nm, using an isocratic mobile phase consisting of methanol and 10 mM potassium dihydrogen phosphate buffer (pH 2.5) in a ratio of 70:30 v/v at a flow rate of 1 mL min-1. The retention times for metformin and repaglinide were found to be 2.6 and 11.3 min, respectively. The drugs were exposed to thermal, photolytic, hydrolytic, and oxidative stress conditions, and the stressed samples were analyzed by the proposed method. Validation of the method was carried out as per International Conference on Harmonization (ICH) guidelines. Linearity was established for metformin and repaglinide in the range of 5–200 μg mL-1 and 1–200 μg m-1. L, respectively. The limits of detection were 0.3 μg mL-1 and 0.13 μg mL-1 for metformin and repaglinide, respectively. The method was found to be specific and stability-indicating as no interfering peaks of degradants and excipients were observed. The proposed method is hence suitable for application in quality-control laboratories for quantitative analysis of both the drugs individually and in combination, since it is simple and rapid with good accuracy and precision.